Search

Displaying results 661 - 670 of 7655 in total
  1. Drug

    Mebrofenin

    go.drugbank.com/drugs/DB15779
    Approved

    Products: Kit for the Preparation of Technetium Tc 99m Mebrofenin
  2. Indication

    Symptomatic for no more than 48 hours.

    go.drugbank.com/conditions/DBCOND0116964
    Drugs: Oseltamivir
    Synonyms: Symptomatic for no more than 48 hours, Symptomatic for no more than 48 hours.
  3. Indication

    Suitable candidate for hematopoietic stem cell transplantation

    go.drugbank.com/conditions/DBCOND0173822
    Drugs: Etuvetidigene Autotemcel
    Synonyms: Suitable candidate for hematopoietic stem cell transplantation
  4. Indication

    High risk for progression to severe disease

    go.drugbank.com/conditions/DBCOND0143965
    Drugs: Anakinra · Dapagliflozin · Empagliflozin · Imdevimab · Metformin · Nirmatrelvir +3 more
    Synonyms: High risk for progression to severe disease
  5. Indication

    ≥ 1 prior therapy for Mantle cell lymphoma

    go.drugbank.com/conditions/DBCOND0093836
    Drugs: Acalabrutinib
    Synonyms: ≥ 1 prior therapy for Mantle cell lymphoma
  6. Drug

    Palonosetron

    go.drugbank.com/drugs/DB00377
    ApprovedInvestigational

    Palonosetron (INN, trade name Aloxi) is an antagonist of 5-HT3 receptors that is indicated for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). … effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy and is the only drug of its class approved for

    Products: Solution for Injection 50mcg/ml, ALOXI Solution for Injection 50mcg/ml
  7. Drug

    Octreotide

    go.drugbank.com/drugs/DB00104
    ApprovedInvestigational

    On June 26, 2020, the first approved delayed-release oral somatostatin analog, Mycapssa, received FDA approval for the long term maintenance treatment of acromegaly. … [L14513] Additionally, it is used for the treatment of acromegaly and symptoms arising from various tumors, including carcinoid tumors and vasoactive intestinal tumors (VIPomas).

    Products: SANDOSTATIN LAR FOR INJECTION 10 mg, SANDOSTATIN LAR FOR INJECTION 20 mg
  8. Drug

    Fosaprepitant

    go.drugbank.com/drugs/DB06717
    ApprovedInvestigational

    Fosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.

    Products: Powder for Solution for Infusion 150mg, Fosaprepitant for Injection
  9. Drug

    Enzacamene

    go.drugbank.com/drugs/DB11219
    Approved

    It is used in cosmetic products such as sunscreen to provide skin protection against UV rays. … Commonly known as 4-methylbenzylidene-camphor (4-MBC), enzacamene is a camphor derivative and an organic chemical UV-B filter.

    Synonyms: Enzacamene D-L formMixtures: mesoestetic moisturizing sun protection BROAD SPECTRUM FOR NORMAL AND DRY SKINS, Conju Princess UV Sun Block
  10. Drug

    Peginterferon beta-1a

    go.drugbank.com/drugs/DB09122
    ApprovedInvestigational

    It was originally approved by the FDA in 2014 for subcutaneous use, and was approved for intramuscular use in January 2021. … [A176474,L5792] Peginterferon beta-1a is an interferon therapy used for the management of relapsing forms of MS.

    Categories: Compounds used in a research, industrial, or household settingProducts: PLEGRIDY®94 UG SOLUCIÓN INYECTABLE.